Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IDT Biologika has more than a century of expertise in vaccine development and manufacturing. It operates as a leading global CDMO with end-to-end services for viral vaccines, viral vectors for cell/gene therapies, oncolytic viruses, protein-based biologics, and sterile injectables. The company has contributed to pandemic response efforts and maintains EMA/FDA/ANVISA approvals. In recent years it recorded positive earnings post-acquisition by SK bioscience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IDT Biologika.